WeVote

Bill

Bill

HB 952

RELATING TO PARKINSON'S DISEASE RESEARCH.

2026 Regular Session Introduced by Terez Amato and 18 co-sponsors

Hawaii bill to support Parkinson's disease research through dedicated funding mechanisms, passed committee with amendments and referred to budget review.

Carried over to 2026 Regular Session.
0
WeVote Research Nonpartisan
Bill Summary · HB 952

Legislative bill overview

HB 952 establishes support for Parkinson's disease research initiatives in Hawaii. The bill passed its second reading with amendments and was referred to the Ways and Means Committee, but was carried over to the 2026 legislative session before final passage. The specific provisions likely include funding mechanisms, research grants, or institutional support for Parkinson's research programs.

Why is this important

Parkinson's disease affects thousands of Hawaiians and represents a growing public health concern as the population ages. Dedicated research funding can accelerate treatment development, improve quality of life for patients, and position Hawaii as a center for neurodegenerative disease research, potentially attracting researchers and economic benefits.

Potential points of contention

  • Fiscal impact: The bill's funding mechanism and budget allocation are not detailed in the action record, raising questions about taxpayer cost and whether resources should prioritize other health conditions
  • Research focus scope: Unclear whether the bill funds only basic research, clinical trials, patient services, or some combination—each approach has different outcomes and cost-effectiveness profiles
  • Accountability measures: No information provided on how research outcomes will be measured, reported, or whether funding will continue if results are insufficient

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.